Ambrisentan in portopulmonary hypertension: A multicenter, open-label trial
Ioana R. Preston, Charles D. Burger, Sonja Bartolome, Zeenat Safdar, Michael J. Krowka, Namita Sood, H. James Ford, Wejdan Battarjee, Murali M. Chakinala, Mardi Gomberg‐Maitland, Nicholas S. Hill
Topics & Concepts
AmbrisentanPortopulmonary hypertensionMedicineInternal medicinePulmonary wedge pressurePulmonary hypertensionCardiologyVascular resistanceBlood pressureOpen labelCardiac indexHemodynamicsClinical trialPortal hypertensionCardiac outputCirrhosisEndothelin receptorReceptorBosentanPulmonary Hypertension Research and TreatmentsHeart Failure Treatment and ManagementCardiovascular Function and Risk Factors